Internal Medicine Alert – November 30, 2012
November 30, 2012
View Issues
-
Bariatric Surgery Reduces the Risk of Type 2 Diabetes
In a prospectively followed cohort of obese, non-diabetic men and women from Sweden, individuals who underwent bariatric surgery had an 83% reduction in the risk of developing type 2 diabetes over 15 years of follow-up. -
Cognitive Function in Breast Cancer Survivors
There has long been an appreciation of the risk of cognitive decline associated with chemotherapy but questions remain about the magnitude and duration of the observed deficits. In this meta-analysis of studies that included neuropsychological assessments at a minimum of 6 months after completion of breast cancer chemotherapy, definite but small deficits were found for both verbal and visuospatial capabilities. -
Controlling Diabetic Neuropathic Pain
Three common medications amitripty-line, duloxetine, and pregabalin all appear equally efficacious in treating neuropathic pain from diabetic neuropathy. -
Pharmacology Update: Tbo-filgrastim Injection
A modified recombinant human granulocyte colony-stimulating factor (G-CSF) has been approved by the FDA. -
Clinical Briefs By Louis Kuritzky, MD
Risk of Cancer in RA Patients Treated with Disease-Modifying Drugs; A Different Kind of Fish Story; Antidepressants and Auto Accidents -
Pharmacology Watch: Do Benzodiazepines Cause Dementia in the Elderly?
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.